Clinical Trial Update: Application of Cell Regeneration Therapy With Mesenchymal Stem Cells From Adipose Tissue in Critical Chronic Ischemic Syndrome of Lower Limbs (CLI) in Nondiabetic Patients. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating adipose-derived mesenchymal stem cells for critical limb ischemia in non-diabetic patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia

Drugs mentioned

• Adipose-derived mesenchymal stem cells

Snippet

Sponsor: Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud | Conditions: Critical Limb Ischemia | Phase 2 | Status: COMPLETED